India Pet Veterinary Diets - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The india pet veterinary diets market size was valued at USD 100.00 million in 2025 and is estimated to grow from USD 112.00 million in 2026 to reach USD 197.40 million by 2031, at a CAGR of 12.0% during the forecast period. This report is Segmented by Sub Product (Diabetes, Renal, Urinary Tract Disease, Digestive Sensitivity, Oral Care Diets, Derma Diets, and More), by Pets (Cats, Dogs, and Other Pets), by Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets/Hypermarkets, and Others). The Market Forecasts are Provided in Terms of Value in USD and Volume in Metric Tons.

India Pet Veterinary Diets Market Trends and Insights

Rising Diagnosis Rates for Chronic Pet Conditions

The India pet veterinary diets market is experiencing growth driven by the increasing prevalence of chronic diseases in companion animals. Conditions such as renal disease, canine diabetes, urinary tract disorders, and digestive issues are being reported more frequently, particularly in urban areas where sedentary lifestyles and calorie-dense feeding habits are common. A prospective study published in the Indian Journal of Animal Research found that in 2025, nephritis and renal failure accounted for 35.88% of renal disorders in dogs in the South Saurashtra region of Gujarat. Similarly, clinical data from Guru Angad Dev Veterinary and Animal Sciences University indicated 6 to 7 cases of renal failure daily and over 200 dialysis sessions during the reported period. Once diagnosed, diet therapy for these conditions often extends for months or even years, creating a recurring demand for therapeutic diets. This recurring demand shifts therapeutic diets from occasional use to a routine component of medical care, particularly for the management of renal, diabetes, and urinary health. As diagnostic capabilities improve and veterinary case management becomes more structured, the India pet veterinary diets market is increasingly driven by clinical necessity rather than general premium food preferences.

Veterinary Telehealth Improves Prescription Diet Access

Telehealth is addressing a significant access barrier in the India pet veterinary diets market by reducing the time between symptom onset and clinical advice. Traditionally reliant on in-person consultations, the market's reach was limited in areas outside major cities, where specialist veterinary services were less accessible. According to IBEF (India Brand Equity Foundation), India’s pet telemedicine segment experienced a 40% growth in demand in previous years, supported by smartphone penetration surpassing 900 million users by late 2024. This increased connectivity facilitates faster digital interactions between pet owners and veterinarians. Remote consultations can seamlessly transition into diet recommendations and online orders, minimizing delays. This efficiency is particularly beneficial for conditions such as digestive sensitivity, obesity, renal issues, and urinary disorders, where timely intervention is crucial. Additionally, telehealth expands access for pet owners in Tier-2 and Tier-3 cities, who may have limited availability of therapeutic products through local clinics. As digital consultations gain wider acceptance in pet care, the India pet veterinary diets market is anticipated to reach a broader audience, including those previously outside the organized treatment network.

High Price Sensitivity Outside Major Cities

Price sensitivity remains a significant restraint on the India pet veterinary diets market, particularly outside major urban areas. The pricing range for leading therapeutic products is INR 800 (USD 9.4) to INR 1,400 (USD 16.5) per kilogram, representing a substantial recurring expense for many households. In smaller cities and semi-urban markets, pet care often competes with other essential household priorities, making long-term therapeutic feeding challenging to sustain. The issue extends beyond the initial purchase to the ongoing need for consistent spending over several months or longer. While pet owners may adopt a therapeutic diet following a diagnosis, they often discontinue it once symptoms improve or when the recurring monthly cost becomes more apparent. The planned 2024 launch of Bowler’s Nutrimax by Allana aims to address this challenge by providing a more affordable premium option positioned between generic and veterinary-grade nutrition. However, unless improvements are made in price segmentation, pack sizes, and compliance support, this restraint will continue to hinder the expansion of the India pet veterinary diets market beyond affluent urban consumers.

Other drivers and restraints analyzed in the detailed report include:

• Rapid Premiumization Among Urban Pet Parents
• E-Commerce Expands Reach Beyond Major Metros
• Low Packaged Food Penetration Versus Home-Cooked Feeding

Segment Analysis

Digestive Sensitivity accounted for 29% of the India pet veterinary diets market share in 2025, making it the largest sub-product category. This dominance is attributed to the high prevalence of gastrointestinal issues in pets, often caused by mixed feeding patterns that combine processed food with home-cooked meals. The segment also benefits from the visibility of symptoms, which prompt pet owners to seek veterinary care more quickly. Renal and Diabetes diets represent the next significant segment of therapeutic demand, driven by the increasing diagnosis of chronic diseases in urban pet populations. Additionally, Urinary Tract Disease, Obesity Diets, Derma Diets, and other Veterinary Diets contribute to the market's depth, enabling brands to address a broader range of clinical conditions.

The market is shifting towards more specialized sub-product offerings rather than broad, generic solutions. Hill’s expanded its Prescription Diet range in early 2024 with the introduction of the z/d Low Fat Hydrolyzed Soy Canine formula and the c/d Multicare Low Fat formulation, signaling a focus on multi-condition therapeutic solutions. Oral Care Diets have emerged as the fastest-growing segment, projected to grow at a 16% CAGR through 2031. This growth is supported by increased awareness of dental diseases and a lower price point compared to some renal and diabetes diets. In response to this demand, Virbac reformulated its HPM Small and Toy range in 2024, emphasizing clinically supported oral health benefits. Within the India pet veterinary diets market, competition among sub-products has shifted focus. The emphasis is now less on whether a condition can be addressed and more on which brand can ensure treatment accessibility through veterinary clinics and verified retail channels.

Complete Report Scope:

• By Sub Product
  • Diabetes
  • Digestive Sensitivity
  • Oral Care Diets
  • Renal
  • Urinary Tract Disease
  • Obesity Diets
  • Derma Diets
  • Other Veterinary Diets
• By Pets
  • Cats
  • Dogs
  • Other Pets
• By Distribution Channel
  • Convenience Stores
  • Online Channel
  • Specialty Stores
  • Supermarkets/Hypermarkets
  • Other Channels

List of Companies Covered in this Report:

• Mars, Incorporated
• Nestlé S.A. (Purina)
• Colgate-Palmolive Company (Hills Pet Nutrition Inc.)
• General Mills, Inc. (Blue Buffalo)
• Virbac
• Drools Pet Food Pvt. Ltd.
• Farmina Pet Foods
• Schell and Kampeter, Inc. (Diamond Pet Food)
• Charoen Pokphand Group
• Godrej Pet Care
• Heads Up For Tails Pvt. Ltd.
• Allana Consumer Products Pvt. Ltd.
• ADM
• PLB International
• Veterinary Nutrition Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support